ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late, 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.

Pharmaceutical

Life Sciences

Biotechnology

ReAlta Life Sciences

Neel K Krishna

John S. Rickman

Kenji M. Cunnion

Linda Dell

Destrey Roberson

The Research Team at ReAlta Life Sciences conducts innovative studies to develop and refine novel drug candidates targeting the Complement System and inflammatory mechanisms. This team, comprised of scientific advisors and research associates, collaborates to design experiments, analyze data, and translate findings into therapeutic strategies that address critical unmet medical needs. Their work plays a crucial role in advancing the company’s mission of delivering life-saving treatments.

Research Team

Clinical Operations Team

Leadership Team

Research Team

About

Team members

Other teams at ReAlta Life Sciences

Clinical Operations Team

Leadership Team